Pargyline

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Pargyline
Skeletal formula of pargyline
Ball-and-stick model of the pargyline molecule
Systematic (IUPAC) name
N-benzyl-N-methylprop-2-yn-1-amine
Clinical data
MedlinePlus a682088
Identifiers
CAS Number 555-57-7 YesY
ATC code C02KC01 C02LL01
PubChem CID 4688
IUPHAR/BPS 7262
DrugBank DB01626 N
ChemSpider 4526 YesY
UNII 9MV14S8G3E YesY
ChEMBL CHEMBL673 YesY
Chemical data
Formula C11H13N
Molar mass 159.23 g/mol
 NYesY (what is this?)  (verify)

Pargyline (Eutonyl) is an irreversible selective monoamine oxidase (MAO)-B inhibitor drug (IC50 for MAO-A is 0.01152 µmol/L and for MAO-B is 0.00820 µmol/L)[1] [2] It was brought to market in the US and the UK by Abbott in 1963 as an antihypertensive drug branded "Eutonyl". It was one of several MAO inhibitors introduced in the 1960s including nialamide, isocarboxazid, phenelzine, and tranylcypromine.[3]:146[4]:60[5][6]

By 2007 the drug was discontinued[7] and as of 2014 there were no generic versions available in the US.[8]

See also[edit]

References[edit]

  1. ^ Fisar Z, Hroudová J, Raboch J. (2010). "Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.". Neuro Endocrinol Lett. 31 (5): 645–56. PMID 21200377. 
  2. ^ Murphy DL, Karoum F, Pickar D, et al. (1998). "Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline)". J. Neural Transm. Suppl. 52: 39–48. doi:10.1007/978-3-7091-6499-0_5. PMID 9564606. 
  3. ^ Edward Shorter, A historical dictionary of psychiatry. Oxford University Press, Inc 2005. ISBN 0195176685
  4. ^ William M. Wardell and Louis Lasagna. Regulation Drug Development (Evaluative Studies 21) American Enterprise Institute (1975) ISBN 0844731676
  5. ^ Council on Drugs New Drugs and Developments in Therapeutics: Pargyline Hydrochloride (Eutonyl) JAMA. 1963;184(11):887. doi:10.1001/jama.1963.03700240079013.
  6. ^ "Eutonyl and MAO inhibitors". Drug and Therapeutics Bulletin 1 (15): 59–60. 15 November 1963. doi:10.1136/dtb.1.15.59. ISSN 1755-5248. Pargyline is promoted only for the treatment of hypertension, and not for depression. 
  7. ^ W. Steven Pray Interactions Between Nonprescription Products and Psychotropic Medications US Pharmacist. 2007;32(11):12-15.
  8. ^ FDA Eutonyl in the Drugs@FDA Database Accessed July 19, 2014